Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tissue Engineered Skin Substitutes for Basal Cell Carcinoma
NCT05234658Phase 2Unknown
- Sponsor
- Red Andaluza de Terapias Avanzadas
- Start
- Jan 2022
- Primary completion
- Jan 2024
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of PHIT in basal cell carcinoma (BCC), sponsored by Red Andaluza de Terapias Avanzadas. Status: unknown.
02
Drugs
PHIT
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT05234658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05234658.